TARSUS PHARMACEUTICALS, INC. Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
TARSUS PHARMACEUTICALS, INC. (TARS) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Earnings Per Share
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2022-11-09
- TARSUS PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2022-09-30 was $0.00.
- TARSUS PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- TARSUS PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- TARSUS PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2021-09-30 was $0.00.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 6 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $43.00K derived: sum of 2 quarters · filed 2022-11-09 | $7.00K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $43.00K 10-Q · filed 2022-08-11 | $124.00K 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $84.00K 10-Q · filed 2022-05-11 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |